Article
p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast.
Cellular oncology (Dordrecht, Netherlands) - 1 Apr 2012
Ercan Cigdem, van Diest Paul J, van der Ende Bram, Hinrichs John, Bult Peter, Buerger Horst, van der Wall Elsken, Derksen Patrick W B
Abstract excerpt
BACKGROUND: p53 is a tumor suppressor that is frequently mutated in human cancers. Although alterations in p53 are common in breast cancer, few studies have specifically investigated TP53 mutations in the breast cancer subtype invasive lobular carcinoma (ILC). Recently reported conditional mouse models have indicated that functional p53 inactivation may play a role in ILC development and progression. Since...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
